Patents by Inventor Chiara Vladiskovic

Chiara Vladiskovic has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10597410
    Abstract: The present invention relates to a process for the preparation of an inhibitor of phosphodiesterase 4, in particular of phosphodiesterase 4B (PDE4B), and intermediates useful for its preparation.
    Type: Grant
    Filed: January 24, 2019
    Date of Patent: March 24, 2020
    Assignee: DIPHARMA FRANCIS S.R.L.
    Inventors: Niccolo′ Santillo, Emanuele Attolino, Davide Brenna, Chiara Vladiskovic, Alessandro Lombardo, Gabriele Razzetti
  • Publication number: 20190241585
    Abstract: The present invention relates to a process for the preparation of an inhibitor of phosphodiesterase 4, in particular of phosphodiesterase 4B (PDE4B), and intermediates useful for its preparation.
    Type: Application
    Filed: January 24, 2019
    Publication date: August 8, 2019
    Applicant: DIPHARMA FRANCIS S.R.L.
    Inventors: Niccolo' Santillo, Emanuele Attolino, Davide Brenna, Chiara Vladiskovic, Alessandro Lombardo, Gabriele Razzetti
  • Patent number: 9687484
    Abstract: The present invention relates to novel crystalline forms of vortioxetine hydrobromide, in particular three crystalline forms, a process for their preparation, a pharmaceutical composition containing said novel crystalline forms, and a process for the purification of vortioxetine or a salt thereof, comprising the formation of one or more of the novel crystalline forms of vortioxetine hydrobromide described herein.
    Type: Grant
    Filed: July 6, 2015
    Date of Patent: June 27, 2017
    Assignee: Dipharma Francis S.r.l.
    Inventors: Stefano Luca Giaffreda, Marco Curzi, Elena Dichiarante, Pietro Allegrini, Renzo Graziosi, Chiara Vladiskovic
  • Publication number: 20160015706
    Abstract: The present invention relates to novel crystalline forms of vortioxetine hydrobromide, in particular three crystalline forms, a process for their preparation, a pharmaceutical composition containing said novel crystalline forms, and a process for the purification of vortioxetine or a salt thereof, comprising the formation of one or more of the novel crystalline forms of vortioxetine hydrobromide described herein.
    Type: Application
    Filed: July 6, 2015
    Publication date: January 21, 2016
    Applicant: DIPHARMA FRANCIS S.r.l.
    Inventors: Stefano Luca GIAFFREDA, Marco CURZI, Elena DICHIARANTE, Pietro ALLEGRINI, Renzo GRAZIOSI, Chiara VLADISKOVIC
  • Patent number: 8884016
    Abstract: Process for the preparation of apixaban and intermediates useful for the preparation thereof.
    Type: Grant
    Filed: June 7, 2012
    Date of Patent: November 11, 2014
    Assignee: Dipharma Francis S.r.l.
    Inventor: Chiara Vladiskovic
  • Publication number: 20140058107
    Abstract: Process for the preparation of apixaban and intermediates useful for the preparation thereof.
    Type: Application
    Filed: June 7, 2012
    Publication date: February 27, 2014
    Applicant: DIPHARMA FRANCIS S.R.L.
    Inventors: Chiara Vladiskovic, Emanuele Attolino, Alessandro Lombardo, Simone Tambini
  • Patent number: 8362260
    Abstract: The present invention relates to novel crystalline forms of Dexlansoprazole and a process for the preparation of amorphous Dexlansoprazole.
    Type: Grant
    Filed: January 26, 2010
    Date of Patent: January 29, 2013
    Assignee: Dipharma Francis S.r.l.
    Inventors: Chiara Vladiskovic, Gabriele Razzetti
  • Patent number: 8314241
    Abstract: Process for the preparation of crystalline anhydrous (R)-2-[[[3-methyl-4-(2,2,2-trifluoroetoxy)-2-piridyl]methyl]sulphinyl]benzimidazole (dexlansoprazole).
    Type: Grant
    Filed: July 6, 2010
    Date of Patent: November 20, 2012
    Assignee: Dipharma Francis S.r.l.
    Inventors: Chiara Vladiskovic, Alessandro Restelli, Gabriele Razzetti
  • Patent number: 7989618
    Abstract: Linezolid salts, useful as such and as intermediates in a process for the preparation of novel and known crystalline linezolid forms, in particular known as Form III.
    Type: Grant
    Filed: September 3, 2008
    Date of Patent: August 2, 2011
    Assignee: DiPharma Francis s.r.l.
    Inventors: Chiara Vladiskovic, Emanuele Attolino, Pietro Allegrini, Gabriele Razzetti
  • Publication number: 20110034523
    Abstract: Disclosed is a crystalline form of rufinamide selected from: a substantially anhydrous and approximately monosolvated with trifluoroacetic acid crystalline form, hereinafter designated as Form ?, and a crystalline form, hereinafter designated as Form ?, characterised by an XRPD spectrum as shown in FIG. 3, wherein the most intense peaks fall at 4.5, 9.0, 13.5, 18.0, 18.8, 19.5, 20.6, 24.6, 25.7, 26.5, 27.4, 27.9, 28.7, 30.0 and 31.8±0.2° in 2?.
    Type: Application
    Filed: August 3, 2010
    Publication date: February 10, 2011
    Applicant: DIPHARMA FRANCIS S.R.L.
    Inventors: Gabriele RAZZETTI, Chiara VLADISKOVIC, Pietro ALLEGRINI
  • Publication number: 20110028728
    Abstract: Process for the preparation of crystalline anhydrous (R)-2-[[[3-methyl-4-(2,2,2-trifluoroetoxy)-2-piridyl]methyl]sulphinyl]benzimidazole (dexlansoprazole).
    Type: Application
    Filed: July 6, 2010
    Publication date: February 3, 2011
    Applicant: DIPHARMA FRANCIS S.r.l.
    Inventors: Chiara VLADISKOVIC, Alessandro Restelli, Gabriele Razzetti
  • Publication number: 20100204479
    Abstract: The present invention relates to novel crystalline forms of Dexlansoprazole and a process for the preparation of amorphous Dexlansoprazole.
    Type: Application
    Filed: January 26, 2010
    Publication date: August 12, 2010
    Applicant: DIPHARMA FRANCIS S.R.I
    Inventors: CHIARA VLADISKOVIC, GABRIELE RAZZETTI
  • Publication number: 20090203915
    Abstract: A process for the preparation of (1S,3?R)-quiniclidin-3?-yl-1-phenyl-3,4-dihydro-1H-isoquinolin-2-carboxylate, namely solifenacin, comprising the reaction of a compound of formula (IV) with a compound of formula (V), as herein defined, and the subsequent reaction with 3-quinuclidinol.
    Type: Application
    Filed: January 30, 2009
    Publication date: August 13, 2009
    Applicant: Dipharma Francis S.r.l.
    Inventors: Pietro Allegrini, Lino Colombo, Marco Brusasca, Chiara Vladiskovic, Gabriele Razzetti, Emanuele Attolino
  • Publication number: 20090062534
    Abstract: Linezolid salts, useful as such and as intermediates in a process for the preparation of novel and known crystalline linezolid forms, in particular known as Form III.
    Type: Application
    Filed: September 3, 2008
    Publication date: March 5, 2009
    Applicant: DIPHARMA FRANCIS s.r.l.
    Inventors: Chiara VLADISKOVIC, Emanuele Attolino, Pietro Allegrini, Gabriele Razzetti